These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 26490983)

  • 21. Long non-coding RNA LUCAT1 is associated with poor prognosis in human non-small lung cancer and regulates cell proliferation via epigenetically repressing p21 and p57 expression.
    Sun Y; Jin SD; Zhu Q; Han L; Feng J; Lu XY; Wang W; Wang F; Guo RH
    Oncotarget; 2017 Apr; 8(17):28297-28311. PubMed ID: 28423699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
    Fan J; Yu H; Lv Y; Yin L
    Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of long noncoding RNA uc.338 predicts poor survival in non-small cell lung cancer.
    Tian Y; Feng Y
    Cancer Biomark; 2018; 22(4):781-785. PubMed ID: 29843223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
    Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA ROR is a novel prognosis factor associated with non-small-cell lung cancer progression.
    Qu CH; Sun QY; Zhang FM; Jia YM
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4087-4091. PubMed ID: 29028092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA PVT1 predicts prognosis and regulates tumor growth in prostate cancer.
    Yang J; Li C; Mudd A; Gu X
    Biosci Biotechnol Biochem; 2017 Dec; 81(12):2301-2306. PubMed ID: 29050519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of p53/p21 expression and cigarette smoking with tumor progression and poor prognosis in non-small cell lung cancer patients.
    Xie D; Lan L; Huang K; Chen L; Xu C; Wang R; Shi Y; Wu X; Wang L; Liu Y; Lu B
    Oncol Rep; 2014 Dec; 32(6):2517-26. PubMed ID: 25333671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer.
    Mao Y; Li W; Chen K; Xie Y; Liu Q; Yao M; Duan W; Zhou X; Liang R; Tao M
    Oncotarget; 2015 Feb; 6(5):3452-61. PubMed ID: 25609202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis.
    Xie X; Liu HT; Mei J; Ding FB; Xiao HB; Hu FQ; Hu R; Wang MS
    Int J Clin Exp Pathol; 2014; 7(12):8881-6. PubMed ID: 25674259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients.
    Zhang J; Wang T; Zhang Y; Wang H; Wu Y; Liu K; Pei C
    Cancer Biomark; 2018; 21(4):763-768. PubMed ID: 29286916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
    Wang D; Hao T; Pan Y; Qian X; Zhou D
    Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circular RNA ciRS-7 correlates with advance disease and poor prognosis, and its down-regulation inhibits cells proliferation while induces cells apoptosis in non-small cell lung cancer.
    Yan B; Zhang W; Mao XW; Jiang LY
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8712-8721. PubMed ID: 30575911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
    Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
    Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
    Yang H; Gao XY; Li P; Jiang TS
    Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p.
    Nie W; Ge HJ; Yang XQ; Sun X; Huang H; Tao X; Chen WS; Li B
    Cancer Lett; 2016 Feb; 371(1):99-106. PubMed ID: 26655272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amplification and the clinical significance of circulating cell-free DNA of PVT1 in breast cancer.
    Li X; Chen W; Wang H; Wei Q; Ding X; Li W
    Oncol Rep; 2017 Jul; 38(1):465-471. PubMed ID: 28534994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circular RNA PVT1 acts as a competing endogenous RNA for miR-497 in promoting non-small cell lung cancer progression.
    Qin S; Zhao Y; Lim G; Lin H; Zhang X; Zhang X
    Biomed Pharmacother; 2019 Mar; 111():244-250. PubMed ID: 30590312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic value of long non coding RNAs in non small cell lung cancer: A meta-analysis.
    Wang M; Ma X; Zhu C; Guo L; Li Q; Liu M; Zhang J
    Oncotarget; 2016 Dec; 7(49):81292-81304. PubMed ID: 27833074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulation of long noncoding RNA PVT1 predicts unfavorable prognosis in patients with clear cell renal cell carcinoma.
    Bao X; Duan J; Yan Y; Ma X; Zhang Y; Wang H; Ni D; Wu S; Peng C; Fan Y; Gao Y; Li X; Chen J; Du Q; Zhang F; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):55-63. PubMed ID: 29081406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MDMX is a prognostic factor for non-small cell lung cancer and regulates its sensitivity to cisplatin.
    Zhao H; Xie YZ; Xing R; Sun M; Chi F; Zeng YC
    Cell Oncol (Dordr); 2017 Aug; 40(4):357-365. PubMed ID: 28567715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.